InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
9
T+90 hit rate
60%
T+90 mean return
+14.0%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Loumeau Eric J, Chief Executive Officer. Officer active across 1 company, notably Anaptysbio, INC. Cumulatively, 28 reports have been recorded. Split: 0 buy · 9 sells. Total volume traded: €1.1m. History available since 4 November 2021. The latest transaction was disclosed on 11 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Loumeau Eric J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
10,000 shares@ US$29.7013.5% of flowCommon StockSEC:0001239648-26-000007:0
5,888 sharesCommon StockSEC:0001239648-26-000006:0
5,545 sharesCommon StockSEC:0001239648-26-000004:0
7,287 sharesCommon StockSEC:0001239648-26-000002:0
2,983 shares@ US$43.267.3% of flowCommon StockSEC:0001239648-26-000002:1
10,000 shares@ US$14.027.9% of flowCommon StockSEC:0001239648-25-000006:0
10,000 shares@ US$51.0028.7% of flowCommon StockSEC:0001239648-25-000006:1
5,000 shares@ US$14.023.7% of flowCommon StockSEC:0001239648-25-000005:0
5,000 shares@ US$14.023.9% of flowCommon StockSEC:0001239648-25-000004:0
7,288 sharesCommon StockSEC:0001415889-25-001042:0
2,994 shares@ US$14.602.8% of flowCommon StockSEC:0001415889-25-001042:1
5,545 sharesCommon StockSEC:0001415889-25-001042:2
2,217 shares@ US$15.302.2% of flowCommon StockSEC:0001415889-25-001042:3
6,000 shares0Common StockSEC:0001415889-24-023551:0
2,220 shares@ US$38.935.1% of flowCommon StockSEC:0001415889-24-023551:1
5,000 shares@ US$14.024.2% of flowCommon StockSEC:0001415889-24-023551:2
6,500 shares@ US$40.1315.4% of flowCommon StockSEC:0001415889-24-023551:3
3,780 shares@ US$38.41038.6% of flowCommon StockSEC:0001415889-24-023551:4
5,000 shares@ US$14.024.3% of flowCommon StockSEC:0001415889-24-004666:0
5,545 shares0Common StockSEC:0001209191-24-001279:0
2,305 shares@ US$21.813.0% of flowCommon StockSEC:0001209191-24-001279:1
882 shares@ US$14.190.8% of flowCommon StockSEC:0001209191-23-056638:0
6,000 sharesCommon StockSEC:0001209191-23-049809:0
523 shares@ US$25.000.8% of flowCommon StockSEC:0001209191-22-045061:0
2,500 shares@ US$14.020.0018% mcap24.1% of flowCommon StockSEC:0001209191-22-036020:0
25 of 28 declarations
About Loumeau Eric J
Eric J. Loumeau is the Chief Operating Officer and General Counsel at AnaptysBio, Inc. He oversees the company's operations while ensuring legal compliance. AnaptysBio is a biopharmaceutical company focused on developing immunological treatments.
